Australia markets close in 5 hours 40 minutes

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
38.78-0.03 (-0.08%)
At close: 04:00PM EDT
37.60 -1.18 (-3.04%)
After hours: 05:26PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.15B
Enterprise value 658.21M
Trailing P/E 3.03
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.28
Price/book (mrq)0.88
Enterprise value/revenue 0.71
Enterprise value/EBITDA 1.20

Trading information

Stock price history

Beta (5Y monthly) 1.55
52-week change 3-56.85%
S&P500 52-week change 3-13.66%
52-week high 3109.55
52-week low 337.33
50-day moving average 348.77
200-day moving average 359.94

Share statistics

Avg vol (3-month) 3307.01k
Avg vol (10-day) 3265.09k
Shares outstanding 530.27M
Implied shares outstanding 6N/A
Float 821.35M
% held by insiders 129.56%
% held by institutions 145.03%
Shares short (30 Aug 2022) 41.39M
Short ratio (30 Aug 2022) 43.86
Short % of float (30 Aug 2022) 47.75%
Short % of shares outstanding (30 Aug 2022) 44.60%
Shares short (prior month 28 July 2022) 41.51M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022

Profitability

Profit margin 42.41%
Operating margin (ttm)57.69%

Management effectiveness

Return on assets (ttm)26.57%
Return on equity (ttm)35.01%

Income statement

Revenue (ttm)925.15M
Revenue per share (ttm)30.77
Quarterly revenue growth (yoy)-18.40%
Gross profit (ttm)777.05M
EBITDA 553.31M
Net income avi to common (ttm)392.38M
Diluted EPS (ttm)12.52
Quarterly earnings growth (yoy)-85.50%

Balance sheet

Total cash (mrq)515.4M
Total cash per share (mrq)17.03
Total debt (mrq)34.62M
Total debt/equity (mrq)2.64
Current ratio (mrq)5.29
Book value per share (mrq)43.11

Cash flow statement

Operating cash flow (ttm)428.82M
Levered free cash flow (ttm)382.6M